Biofrontera Inc. (BFRI)
NASDAQ: BFRI · IEX Real-Time Price · USD
1.590
-0.120 (-7.02%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Biofrontera Revenue
In the year 2023, Biofrontera had annual revenue of $34.07M with 18.82% growth. Revenue in the quarter ending December 31, 2023 was $10.60M with 4.46% year-over-year growth.
Revenue (ttm)
$34.07M
Revenue Growth
+18.82%
P/S Ratio
0.24
Revenue / Employee
$410,494
Employees
83
Market Cap
8.09M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 34.07M | 5.40M | 18.82% |
Dec 31, 2022 | 28.67M | 4.57M | 18.98% |
Dec 31, 2021 | 24.10M | 5.25M | 27.86% |
Dec 31, 2020 | 18.85M | -7.33M | -28.01% |
Dec 31, 2019 | 26.18M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Molecular Templates | 57.31M |
Cosmos Health | 49.59M |
Universe Pharmaceuticals INC | 32.31M |
Precipio | 15.20M |
Vaccinex | 570.00K |
Notable Labs | 310.00K |
BioRestorative Therapies | 145.80K |
Kazia Therapeutics | 15.65K |
BFRI News
- 4 weeks ago - Biofrontera Inc. Announces 2024 Annual Meeting of Stockholders and Deadlines for Submission of Stockholder Proposals - Accesswire
- 6 weeks ago - CORRECTION: Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update - Accesswire
- 6 weeks ago - Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update - Accesswire
- 7 weeks ago - Biofrontera Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 15, 2024 - Accesswire
- 7 weeks ago - Medicus Pharma Ltd. Announces Appointment of Erica Monaco as Chief Operating Officer - Newsfile Corp
- 2 months ago - Biofrontera Inc. Announces Closing of Private Placement of up to $16.0 Million Priced at Market per Nasdaq Rules - Accesswire
- 2 months ago - Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera AG - Accesswire
- 2 months ago - Biofrontera Inc. Announces Private Placement of Up To $16.0 Million Priced at Market per Nasdaq Rules - Accesswire